Vincenzo Catalano

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini et al. · British Journal of Cancer · 2009 · 561 citations · Full text

Medicine, Genetics, Oncology +17

Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

Stefano Cascinu, Vincenzo Catalano, L. Cordella et al. · Journal of Clinical Oncology · 2002 · 416 citations

Medicine, Oncology, Pharmacology +17

Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.

Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli et al. · PubMed · 2012 · 331 citations

Medicine, Oncology, Pharmacology +17

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · Journal of Clinical Oncology · 2007 · 266 citations · Full text

Medicine, Oncology, Pharmacology +17

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

Giuseppe Perrone, Pier Adelchi Ruffini, Vincenzo Catalano et al. · European Journal of Cancer · 2008 · 210 citations

Medicine, Immunology, Oncology +15